Cargando…
The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, a...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164003/ https://www.ncbi.nlm.nih.gov/pubmed/34973094 http://dx.doi.org/10.1007/s10557-021-07282-z |
_version_ | 1785037998810726400 |
---|---|
author | Zheng, Guanghui He, Fenglian Xu, Jing Hu, Juntao Ge, Weiwei Ji, Xianfei Wang, Changsheng Bradley, Jennifer L. Peberdy, Mary Ann Ornato, Joseph P. Jiang, Longyuan Toldo, Stefano Wang, Tong Tang, Wanchun |
author_facet | Zheng, Guanghui He, Fenglian Xu, Jing Hu, Juntao Ge, Weiwei Ji, Xianfei Wang, Changsheng Bradley, Jennifer L. Peberdy, Mary Ann Ornato, Joseph P. Jiang, Longyuan Toldo, Stefano Wang, Tong Tang, Wanchun |
author_sort | Zheng, Guanghui |
collection | PubMed |
description | PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, and (3) sham. Each group consisted of a 6 h non-survival subgroup (n = 6) and a 48 h survival subgroup (n = 6). Ventricular fibrillation (VF) was induced and untreated for 6 min. CPR was initiated and continued for 8 min. Resuscitation was attempted with a 4 J defibrillation. MCC950 (10 mg/kg) or vehicle was administered via intraperitoneal injection immediately after the return of spontaneous circulation (ROSC). Myocardial function and sublingual microcirculation were measured after ROSC in the non-survival subgroups. Plasma levels of interleukin Iβ (IL-1β) and cardiac troponin I (cTnI) were measured at baseline and 6 h in the non-survival subgroups. Heart tissue was harvested to measure the NLRP3 inflammasome constituents, including NLRP3, apoptosis-associated speck-like protein (ASC), Caspase-1, and IL-1β. Survival duration and neurologic deficit score (NDS) were recorded and evaluated among survival groups. RESULTS: Post-resuscitation myocardial function and sublingual microcirculation were improved in MCC950 compared with control (p < 0.05). IL-1β and cTnI were decreased in MCC950 compared to control (p < 0.01). The MCC950 treated groups showed significantly reduced ASC, caspase-1, and IL-1β compared with the control group (p < 0.05). Survival at 48 h after ROSC was greater in MCC950 (p < 0.05) with improved NDS (p < 0.05). CONCLUSION: Administration of MCC950 following ROSC mitigates post-resuscitation myocardial dysfunction and improves survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10557-021-07282-z. |
format | Online Article Text |
id | pubmed-10164003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-101640032023-05-08 The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation Zheng, Guanghui He, Fenglian Xu, Jing Hu, Juntao Ge, Weiwei Ji, Xianfei Wang, Changsheng Bradley, Jennifer L. Peberdy, Mary Ann Ornato, Joseph P. Jiang, Longyuan Toldo, Stefano Wang, Tong Tang, Wanchun Cardiovasc Drugs Ther Original Article PURPOSE: To investigate the effects of the selective NLRP3 inflammasome inhibitor MCC950 on post-resuscitation myocardial function and survival in a rat model of cardiopulmonary resuscitation (CPR). METHODS: Thirty-six Sprague Dawley rats were randomized into three groups: (1) MCC950, (2) control, and (3) sham. Each group consisted of a 6 h non-survival subgroup (n = 6) and a 48 h survival subgroup (n = 6). Ventricular fibrillation (VF) was induced and untreated for 6 min. CPR was initiated and continued for 8 min. Resuscitation was attempted with a 4 J defibrillation. MCC950 (10 mg/kg) or vehicle was administered via intraperitoneal injection immediately after the return of spontaneous circulation (ROSC). Myocardial function and sublingual microcirculation were measured after ROSC in the non-survival subgroups. Plasma levels of interleukin Iβ (IL-1β) and cardiac troponin I (cTnI) were measured at baseline and 6 h in the non-survival subgroups. Heart tissue was harvested to measure the NLRP3 inflammasome constituents, including NLRP3, apoptosis-associated speck-like protein (ASC), Caspase-1, and IL-1β. Survival duration and neurologic deficit score (NDS) were recorded and evaluated among survival groups. RESULTS: Post-resuscitation myocardial function and sublingual microcirculation were improved in MCC950 compared with control (p < 0.05). IL-1β and cTnI were decreased in MCC950 compared to control (p < 0.01). The MCC950 treated groups showed significantly reduced ASC, caspase-1, and IL-1β compared with the control group (p < 0.05). Survival at 48 h after ROSC was greater in MCC950 (p < 0.05) with improved NDS (p < 0.05). CONCLUSION: Administration of MCC950 following ROSC mitigates post-resuscitation myocardial dysfunction and improves survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10557-021-07282-z. Springer US 2022-01-01 2023 /pmc/articles/PMC10164003/ /pubmed/34973094 http://dx.doi.org/10.1007/s10557-021-07282-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Zheng, Guanghui He, Fenglian Xu, Jing Hu, Juntao Ge, Weiwei Ji, Xianfei Wang, Changsheng Bradley, Jennifer L. Peberdy, Mary Ann Ornato, Joseph P. Jiang, Longyuan Toldo, Stefano Wang, Tong Tang, Wanchun The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title | The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title_full | The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title_fullStr | The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title_full_unstemmed | The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title_short | The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation |
title_sort | selective nlrp3-inflammasome inhibitor mcc950 mitigates post-resuscitation myocardial dysfunction and improves survival in a rat model of cardiac arrest and resuscitation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164003/ https://www.ncbi.nlm.nih.gov/pubmed/34973094 http://dx.doi.org/10.1007/s10557-021-07282-z |
work_keys_str_mv | AT zhengguanghui theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT hefenglian theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT xujing theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT hujuntao theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT geweiwei theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT jixianfei theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT wangchangsheng theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT bradleyjenniferl theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT peberdymaryann theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT ornatojosephp theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT jianglongyuan theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT toldostefano theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT wangtong theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT tangwanchun theselectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT zhengguanghui selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT hefenglian selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT xujing selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT hujuntao selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT geweiwei selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT jixianfei selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT wangchangsheng selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT bradleyjenniferl selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT peberdymaryann selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT ornatojosephp selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT jianglongyuan selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT toldostefano selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT wangtong selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation AT tangwanchun selectivenlrp3inflammasomeinhibitormcc950mitigatespostresuscitationmyocardialdysfunctionandimprovessurvivalinaratmodelofcardiacarrestandresuscitation |